[go: up one dir, main page]

CN115400600B - A kind of hollow fiber composite membrane and its preparation method and application - Google Patents

A kind of hollow fiber composite membrane and its preparation method and application Download PDF

Info

Publication number
CN115400600B
CN115400600B CN202211021897.7A CN202211021897A CN115400600B CN 115400600 B CN115400600 B CN 115400600B CN 202211021897 A CN202211021897 A CN 202211021897A CN 115400600 B CN115400600 B CN 115400600B
Authority
CN
China
Prior art keywords
hollow fiber
polyethersulfone
spinning solution
fiber composite
composite membrane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202211021897.7A
Other languages
Chinese (zh)
Other versions
CN115400600A (en
Inventor
董凡
阮万民
祁腾腾
黄臣勇
曾凯
范斌
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhuhai Jianfan Blood Purification Technology Co ltd
Jafron Biomedical Co Ltd
Original Assignee
Zhuhai Jianhang Medical Technology Co ltd
Jafron Biomedical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhuhai Jianhang Medical Technology Co ltd, Jafron Biomedical Co Ltd filed Critical Zhuhai Jianhang Medical Technology Co ltd
Priority to CN202211021897.7A priority Critical patent/CN115400600B/en
Publication of CN115400600A publication Critical patent/CN115400600A/en
Application granted granted Critical
Publication of CN115400600B publication Critical patent/CN115400600B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D69/00Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor
    • B01D69/08Hollow fibre membranes
    • B01D69/087Details relating to the spinning process
    • B01D69/088Co-extrusion; Co-spinning
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D69/00Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor
    • B01D69/08Hollow fibre membranes
    • B01D69/087Details relating to the spinning process
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D69/00Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor
    • B01D69/10Supported membranes; Membrane supports
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D69/00Semi-permeable membranes for separation processes or apparatus characterised by their form, structure or properties; Manufacturing processes specially adapted therefor
    • B01D69/10Supported membranes; Membrane supports
    • B01D69/105Support pretreatment
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D71/00Semi-permeable membranes for separation processes or apparatus characterised by the material; Manufacturing processes specially adapted therefor
    • B01D71/06Organic material
    • B01D71/66Polymers having sulfur in the main chain, with or without nitrogen, oxygen or carbon only
    • B01D71/68Polysulfones; Polyethersulfones
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D2323/00Details relating to membrane preparation
    • B01D2323/02Hydrophilization
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D2323/00Details relating to membrane preparation
    • B01D2323/12Specific ratios of components used
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B01PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01DSEPARATION
    • B01D2325/00Details relating to properties of membranes
    • B01D2325/36Hydrophilic membranes
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A20/00Water conservation; Efficient water supply; Efficient water use
    • Y02A20/124Water desalination
    • Y02A20/131Reverse-osmosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • External Artificial Organs (AREA)

Abstract

The invention provides a hollow fiber composite membrane, a preparation method and application thereof, wherein the preparation method of the hollow fiber composite membrane comprises the following steps: uniformly mixing the modified polyethersulfone mixture, the hydrophilic additive and the organic solvent to prepare a separation layer spinning solution; uniformly mixing the modified polyethersulfone mixture, the plasticizer, the pore-forming agent and the organic solvent to prepare a supporting layer spinning solution; forming an initial membrane by a coextrusion process of the separation layer spinning solution, the support layer spinning solution and the core solution, and solidifying and cleaning the initial membrane to obtain a hollow fiber composite membrane; the modified polyethersulfone mixture comprises polyethersulfone and/or end hydroxylated polyethersulfone. The invention solves the problems that the existing hollow fiber membrane is not easy to realize large-scale production, and the performance consistency is poor, so that the production cost of the hollow fiber membrane is increased.

Description

一种中空纤维复合膜及其制备方法和应用A kind of hollow fiber composite membrane and its preparation method and application

技术领域technical field

本发明涉及血液净化材料技术领域,具体而言,涉及一种中空纤维复合膜及其制备方法和应用。The invention relates to the technical field of blood purification materials, in particular to a hollow fiber composite membrane and its preparation method and application.

背景技术Background technique

血液透析是指利用弥散、超滤和对流原理清除血液中有害物质和过多水分的血液净化技术,是最常用的肾脏替代治疗方法之一,也可以用于治疗药物过量或毒物中毒。血液滤过是以对流方式清除体内过多的水分和尿毒症毒素的医用技术。血液透析滤过是血液透析和血液滤过的结合,具有两种治疗模式的优点,可通过弥散和对流两种机制清除溶质。Hemodialysis refers to the blood purification technology that uses the principles of diffusion, ultrafiltration and convection to remove harmful substances and excess water in the blood. It is one of the most commonly used renal replacement therapy methods and can also be used to treat drug overdose or poisoning. Hemofiltration is a medical technique that convectively removes excess water and uremic toxins from the body. Hemodiafiltration is a combination of hemodialysis and hemofiltration, offering the advantages of both modes of treatment, removing solutes by both diffusion and convection mechanisms.

超滤膜是实现上述医用技术的最主要部件。超滤膜的表面化学组成和亲水性能对膜的血液相容性有极大影响。目前常用的血液透析、血液滤过和血液透析滤过膜有聚砜(PSF)、聚醚砜(PES),这两种膜材料本身的亲水性较差,因而血液相容性不尽人意。常用的改进方法是加入聚乙烯吡咯烷酮(PVP)或聚乙二醇(PEG)等亲水性物质进行共混改性或者在膜表面进行涂敷改性,制成改性的血液透析、血液滤过和血液透析滤过膜,提高膜材的亲水性,改善膜材的血液相容性。Ultrafiltration membrane is the most important component to realize the above medical technology. The surface chemical composition and hydrophilic properties of ultrafiltration membranes have a great influence on the blood compatibility of the membranes. At present, the commonly used hemodialysis, hemofiltration and hemodiafiltration membranes include polysulfone (PSF) and polyethersulfone (PES). These two membrane materials have poor hydrophilicity, so blood compatibility is not satisfactory. . The commonly used improvement method is to add hydrophilic substances such as polyvinylpyrrolidone (PVP) or polyethylene glycol (PEG) for blending modification or coating modification on the membrane surface to make modified hemodialysis, hemofiltration Through and hemodiafiltration membrane, improve the hydrophilicity of the membrane material, and improve the blood compatibility of the membrane material.

但是加入聚乙烯吡咯烷酮(PVP)或聚乙二醇(PEG)等亲水性物质进行共混改性制膜,虽然便利且容易实现规模化生产,但是膜的分离层和支撑层属于同一配方体系,在膜结构控制上难以根据实际需要分别对分离层和支撑层配方进行调控,即无法通过配方调控来实现分离层和支撑层在结构和性能上的差异化控制。在基膜表面涂敷改性是一个分步制膜过程,即先制备基膜,然后在基膜表面进行第二步涂敷制膜,该方法虽然可以根据实际需要对基膜和涂敷层进行分布制备,但不容易实现规模化生产,且性能一致性较差,导致膜的生产成本增加。However, adding hydrophilic substances such as polyvinylpyrrolidone (PVP) or polyethylene glycol (PEG) to blend and modify the membrane is convenient and easy to achieve large-scale production, but the separation layer and support layer of the membrane belong to the same formula system In terms of membrane structure control, it is difficult to adjust the formulations of the separation layer and support layer according to actual needs, that is, it is impossible to achieve differential control of the structure and performance of the separation layer and support layer through formulation regulation. Coating modification on the surface of the base film is a step-by-step film-making process, that is, the base film is prepared first, and then the second step is applied on the surface of the base film to form a film. Although this method can be modified according to actual needs, the base film and the coating layer Distributed preparation is carried out, but it is not easy to achieve large-scale production, and the performance consistency is poor, resulting in an increase in the production cost of the membrane.

有鉴于此,有必要提供一种易于实现规模化生产,性能一致性较好,并能够降低生产成本的中空纤维复合膜的制备方法。In view of this, it is necessary to provide a method for preparing hollow fiber composite membranes that is easy to realize large-scale production, has good performance consistency, and can reduce production costs.

发明内容Contents of the invention

本发明旨在解决现有的中空纤维膜不易于实现规模化生产,且性能一致性较差,导致增加中空纤维膜生产成本的问题。The invention aims to solve the problem that the existing hollow fiber membranes are not easy to realize large-scale production, and the performance consistency is poor, which leads to the increase of the production cost of the hollow fiber membranes.

为解决上述问题,本发明第一方面提供了一种中空纤维复合膜的制备方法,包括如下步骤:In order to solve the above problems, the first aspect of the present invention provides a method for preparing a hollow fiber composite membrane, comprising the steps of:

将改性聚醚砜混合物、亲水性添加剂和有机溶剂混合均匀,制得分离层纺丝溶液;uniformly mixing the modified polyethersulfone mixture, the hydrophilic additive and the organic solvent to prepare a separation layer spinning solution;

将改性聚醚砜混合物、增塑剂、致孔剂和有机溶剂混合均匀,制得支撑层纺丝溶液;uniformly mixing the modified polyethersulfone mixture, plasticizer, porogen and organic solvent to prepare a spinning solution for the support layer;

所述分离层纺丝溶液、所述支撑层纺丝溶液和芯液通过共挤出工艺,形成初始膜,所述初始膜经过凝固和清洗后,制得中空纤维复合膜;The separation layer spinning solution, the supporting layer spinning solution and the core liquid are coextruded to form an initial membrane, and the initial membrane is solidified and cleaned to obtain a hollow fiber composite membrane;

其中,所述改性聚醚砜混合物包括聚醚砜和/或端羟基化聚醚砜。Wherein, the modified polyethersulfone mixture includes polyethersulfone and/or hydroxylated polyethersulfone.

进一步地,所述分离层纺丝溶液采用如下方法制得:Further, the separation layer spinning solution is prepared by the following method:

将质量百分比为15%至35%的改性聚醚砜混合物、25%至40%的亲水性添加剂和45%至60%的有机溶剂在30℃至80℃下混合12h至24h,经过过滤和真空脱泡后,制得分离层纺丝溶液。Mix 15% to 35% of the modified polyethersulfone mixture, 25% to 40% of the hydrophilic additive and 45% to 60% of the organic solvent at 30°C to 80°C for 12h to 24h, and filter After degassing and vacuum degassing, a separation layer spinning solution was prepared.

进一步地,所述亲水性添加剂为聚乙二醇、醋酸纤维素、聚乙烯醇和聚甲基丙烯酸甲酯中的一种或两种的组合;Further, the hydrophilic additive is one or a combination of polyethylene glycol, cellulose acetate, polyvinyl alcohol and polymethyl methacrylate;

所述有机溶剂为磷酸三乙酯、N-甲基甲酰胺、N,N-二甲基乙酰胺、N-甲基吡咯烷酮中的一种或两种的组合。The organic solvent is one or a combination of triethyl phosphate, N-methylformamide, N,N-dimethylacetamide and N-methylpyrrolidone.

进一步地,所述支撑层纺丝溶液采用如下方法制得:Further, the spinning solution for the support layer is prepared by the following method:

将质量百分比为10%至25%的改性聚醚砜混合物、5%至30%的增塑剂、15%至40%的致孔剂和30%至65%的有机溶剂在30℃至80℃下混合12h至24h,经过过滤和真空脱泡后,制得支撑层纺丝溶液。The mass percentage is 10% to 25% of the modified polyethersulfone mixture, 5% to 30% of the plasticizer, 15% to 40% of the porogen and 30% to 65% of the organic solvent at 30 ℃ to 80 Mixing at ℃ for 12h to 24h, after filtering and vacuum defoaming, the spinning solution for the support layer is prepared.

进一步地,所述增塑剂为聚乙烯吡咯烷酮、聚乙二醇、羧甲基纤维素、羟乙基纤维素和聚甲基丙烯酸甲酯中的一种或两种的组合;Further, the plasticizer is one or a combination of polyvinylpyrrolidone, polyethylene glycol, carboxymethylcellulose, hydroxyethylcellulose and polymethylmethacrylate;

致孔剂为乙醇、乙二醇、异丙醇、乙二醇单甲醚、一缩二乙二醇、二缩二乙二醇和丙三醇中的一种或两种的组合;The porogen is one or a combination of ethanol, ethylene glycol, isopropanol, ethylene glycol monomethyl ether, diethylene glycol, diethylene glycol and glycerol;

所述有机溶剂为磷酸三乙酯、N-甲基甲酰胺、N,N-二甲基乙酰胺、N-甲基吡咯烷酮中的一种或两种的组合。The organic solvent is one or a combination of triethyl phosphate, N-methylformamide, N,N-dimethylacetamide and N-methylpyrrolidone.

进一步地,所述分离层纺丝溶液中的改性聚醚砜混合物包括聚醚砜和端羟基化聚醚砜,或者,所述改性聚醚砜混合物为端羟基化聚醚砜;Further, the modified polyethersulfone mixture in the spinning solution of the separation layer includes polyethersulfone and hydroxylated polyethersulfone, or, the modified polyethersulfone mixture is hydroxylated polyethersulfone;

所述支撑层纺丝溶液中的改性聚醚砜混合物包括聚醚砜和端羟基化聚醚砜,或者,所述改性聚醚砜混合物为聚醚砜。The modified polyethersulfone mixture in the spinning solution for the support layer includes polyethersulfone and hydroxylated polyethersulfone, or the modified polyethersulfone mixture is polyethersulfone.

进一步地,所述初始膜采用如下方法制得:Further, the initial film is prepared by the following method:

将所述分离层纺丝溶液、所述支撑层纺丝溶液和所述芯液同时从三孔环形喷丝头中挤出,制得初始膜,其中,所述三孔环形喷丝头包括从内至外依次设置的芯液通道、分离层溶液通道和支撑层溶液通道,所述芯液从所述芯液通道挤出,所述分离层纺丝溶液从所述分离层溶液通道挤出,所述支撑层纺丝溶液从所述支撑层溶液通道挤出。The separation layer spinning solution, the supporting layer spinning solution and the core liquid are simultaneously extruded from a three-hole annular spinneret to prepare an initial film, wherein the three-hole annular spinneret includes The core liquid channel, the separation layer solution channel and the support layer solution channel arranged in sequence from inside to outside, the core liquid is extruded from the core liquid channel, and the separation layer spinning solution is extruded from the separation layer solution channel, The support layer spinning solution is extruded from the support layer solution channel.

进一步地,所述初始膜采用如下方法进行凝固:Further, the initial film is solidified by the following method:

所述初始膜依次经过空气段和凝固浴进行凝固,其中,所述空气段的相对湿度为30%至90%,温度为30℃至50℃,所述初始膜在所述空气段的停留时间为0.5s至1.5s;所述凝固浴由水和致孔剂混合制得,或所述凝固浴由水和有机溶剂混合制得,所述凝固浴的液面高度保持恒定。The initial film is solidified sequentially through the air section and the coagulation bath, wherein the relative humidity of the air section is 30% to 90%, the temperature is 30°C to 50°C, and the residence time of the initial film in the air section is 0.5s to 1.5s; the coagulation bath is made by mixing water and a porogen, or the coagulation bath is made by mixing water and an organic solvent, and the liquid level of the coagulation bath is kept constant.

本发明第二方面提供了一种中空纤维复合膜,采用如第一方面任一项所述的中空纤维复合膜的制备方法制得。The second aspect of the present invention provides a hollow fiber composite membrane, which is prepared by the method for preparing a hollow fiber composite membrane according to any one of the first aspect.

本发明第三方面提供了一种如第二方面所述的中空纤维复合膜在血液透析中的应用。The third aspect of the present invention provides an application of the hollow fiber composite membrane as described in the second aspect in hemodialysis.

本发明所述的中空纤维复合膜的制备方法,以改性聚醚砜混合物制备分离层纺丝溶液和支撑层纺丝溶液,改性聚醚砜混合物中包括聚醚砜和/或端羟基化聚醚砜,端羟基聚醚砜是一种非水溶性的亲水改性聚醚砜,其与聚醚砜共混后成膜,能够改善中空纤维复合膜的亲水性能,提高中空纤维复合膜的血液相容性;在成膜的过程中端羟基聚醚砜中的端羟基能够与亲水性物质(如水溶性PVP或PEG分子等)形成氢键,使得亲水性物质锚定在中空纤维复合膜的表面,能够进一步提高中空纤维复合膜的血液相容性,并且端羟基聚醚砜中的端羟基与亲水物质通过氢键连接,使亲水物质能够更牢固地结合到成膜物质上,避免亲水性物质发生脱落或溶出等现象;而且聚醚砜具有优异的机械性能,将其作为支撑层纺丝溶液有利于提高中空纤维复合膜的结构强度;此外,通过分开调控分离层纺丝溶液和支撑层纺丝溶液的制膜配方,可以制备亲水性分离层,使分离层表面和孔隙形成水化层提高亲水性,以改善中空纤维复合膜的血液相容性,同时可调控分离层壁厚,降低中空纤维复合膜的过滤阻力,而支撑层可以通过调节支撑层纺丝溶液的制膜配方制备多孔层,以进一步降低中空纤维复合膜的过滤阻力,并且分离层纺丝溶液和支撑层纺丝溶液使用结构相似的主体材料,在一步成膜的过程中,能够使分离层和支撑层的界面分子缠绕地更加牢固,使两者的结合强度更加稳定。The preparation method of the hollow fiber composite membrane described in the present invention uses a modified polyethersulfone mixture to prepare a separation layer spinning solution and a support layer spinning solution, and the modified polyethersulfone mixture includes polyethersulfone and/or terminal hydroxylation Polyethersulfone, hydroxyl-terminated polyethersulfone is a water-insoluble hydrophilic modified polyethersulfone, which can be blended with polyethersulfone to form a film, which can improve the hydrophilic performance of the hollow fiber composite membrane and improve the hollow fiber composite membrane. The blood compatibility of the membrane; in the process of film formation, the terminal hydroxyl groups in the hydroxyl-terminated polyethersulfone can form hydrogen bonds with hydrophilic substances (such as water-soluble PVP or PEG molecules, etc.), so that the hydrophilic substances are anchored in the hollow The surface of the fiber composite membrane can further improve the blood compatibility of the hollow fiber composite membrane, and the terminal hydroxyl groups in the hydroxyl-terminated polyethersulfone are connected to the hydrophilic substance through hydrogen bonds, so that the hydrophilic substance can be more firmly bound to the membrane. In terms of material, it is necessary to avoid falling off or dissolution of hydrophilic substances; and polyethersulfone has excellent mechanical properties, and using it as a supporting layer spinning solution is beneficial to improve the structural strength of the hollow fiber composite membrane; in addition, through separate regulation and separation The membrane-making formula of layer spinning solution and supporting layer spinning solution can prepare a hydrophilic separation layer, so that the surface of the separation layer and pores form a hydration layer to improve hydrophilicity, so as to improve the blood compatibility of the hollow fiber composite membrane, At the same time, the wall thickness of the separation layer can be adjusted to reduce the filtration resistance of the hollow fiber composite membrane, and the support layer can be prepared by adjusting the membrane formulation of the support layer spinning solution to prepare a porous layer to further reduce the filtration resistance of the hollow fiber composite membrane, and the separation layer The spinning solution and the supporting layer spinning solution use a similar structure of the main material, in the one-step film forming process, the interface molecules of the separation layer and the supporting layer can be entangled more firmly, and the bonding strength of the two is more stable.

另外,分离层纺丝溶液、支撑层纺丝溶液和芯液通过共挤出工艺通过共挤出工艺制备中空纤维复合膜,能够实现一步成膜,便于规模化生产,且通过共挤出工艺制膜,不仅能够将与血液直接接触的亲水性分离层结合在支撑层上,改善中空纤维复合膜的血液相容性,也可以分开调控分离层和支撑层的制膜配方,优化中空纤维复合膜的结构,改善中空纤维复合膜的性能。In addition, the separation layer spinning solution, the supporting layer spinning solution and the core solution are co-extruded to prepare the hollow fiber composite membrane through the co-extrusion process, which can realize one-step film formation and facilitate large-scale production, and can be produced through the co-extrusion process. The membrane can not only combine the hydrophilic separation layer in direct contact with the blood with the support layer to improve the blood compatibility of the hollow fiber composite membrane, but also can separately control the membrane formulation of the separation layer and the support layer to optimize the hollow fiber composite membrane. The structure of the membrane improves the performance of the hollow fiber composite membrane.

附图说明Description of drawings

图1为本发明实施例提供的制备中空纤维复合膜的流程图;Fig. 1 is the flow chart of the preparation hollow fiber composite membrane provided by the embodiment of the present invention;

图2为本发明实施例提供的三孔环形喷丝头的结构示意图;Fig. 2 is the structural representation of the three-hole annular spinneret provided by the embodiment of the present invention;

图3为本发明实施例1制得的中空纤维复合膜的断面电镜图;Fig. 3 is the cross-section electron micrograph of the hollow fiber composite membrane that the embodiment of the present invention 1 makes;

图4为本发明实施例1制得的中空纤维膜的分离层的断面电镜图。Fig. 4 is a cross-sectional electron micrograph of the separation layer of the hollow fiber membrane prepared in Example 1 of the present invention.

附图标记说明:Explanation of reference signs:

200-芯液通道;210-分离层溶液通道;220-支撑层溶液通道。200-core fluid channel; 210-separation layer solution channel; 220-support layer solution channel.

具体实施方式Detailed ways

为使本发明的上述目的、特征和优点能够更为明显易懂,下面结合附图对本发明的具体实施例做详细的说明。In order to make the above objects, features and advantages of the present invention more comprehensible, specific embodiments of the present invention will be described in detail below in conjunction with the accompanying drawings.

需要说明的是,在不冲突的情况下,本发明中的实施例及实施例中的特征可以相互组合。It should be noted that, in the case of no conflict, the embodiments of the present invention and the features in the embodiments can be combined with each other.

另外,术语“包含”、“包括”、“含有”、“具有”的含义是非限制性的,即可加入不影响结果的其它步骤和其它成分。如无特殊说明的,材料、设备、试剂均为市售。In addition, the meanings of the terms "comprising", "comprising", "containing" and "having" are non-limiting, that is, other steps and other components that do not affect the result can be added. Unless otherwise specified, materials, equipment, and reagents are commercially available.

此外,本发明虽然对制备中的各步骤进行了如步骤S100、步骤S200、步骤S300等形式的描述,但此描述方式仅为了便于理解,如步骤S100、步骤S200、步骤S300等形式并不表示对各步骤先后顺序的限定。In addition, although the present invention describes each step in the preparation such as step S100, step S200, step S300, etc., this description is only for the convenience of understanding, such as step S100, step S200, step S300, etc. does not mean Restrictions on the sequence of steps.

结合图1所示,本发明实施例提供了一种中空纤维复合膜的制备方法,包括如下步骤:As shown in Figure 1, the embodiment of the present invention provides a method for preparing a hollow fiber composite membrane, comprising the following steps:

步骤S100、将改性聚醚砜混合物、亲水性添加剂和有机溶剂混合均匀,制得分离层纺丝溶液;Step S100, uniformly mixing the modified polyethersulfone mixture, the hydrophilic additive and the organic solvent to prepare a separation layer spinning solution;

步骤S200、将改性聚醚砜混合物、增塑剂、致孔剂和有机溶剂混合均匀,制得支撑层纺丝溶液;Step S200, uniformly mixing the modified polyethersulfone mixture, plasticizer, porogen and organic solvent to prepare a spinning solution for the support layer;

步骤S300、分离层纺丝溶液、支撑层纺丝溶液和芯液通过共挤出工艺,形成初始膜,初始膜经过凝固和清洗后,制得中空纤维复合膜;Step S300, the separation layer spinning solution, the supporting layer spinning solution and the core solution are co-extruded to form an initial membrane, and after the initial membrane is solidified and cleaned, a hollow fiber composite membrane is obtained;

其中,改性聚醚砜混合物包括聚醚砜和/或端羟基化聚醚砜。Wherein, the modified polyethersulfone mixture includes polyethersulfone and/or hydroxylated polyethersulfone.

本实施例中提供的中空纤维复合膜的制备方法,以改性聚醚砜混合物制备分离层纺丝溶液和支撑层纺丝溶液,改性聚醚砜混合物中包括聚醚砜和/或端羟基化聚醚砜,端羟基聚醚砜是一种非水溶性的亲水改性聚醚砜,其与聚醚砜共混后成膜,能够改善中空纤维复合膜的亲水性能,提高中空纤维复合膜的血液相容性;在成膜的过程中端羟基聚醚砜中的端羟基能够与亲水性物质(如水溶性PVP或PEG分子等)形成氢键,使得亲水性物质锚定在中空纤维复合膜的表面,能够进一步提高中空纤维复合膜的血液相容性,并且端羟基聚醚砜中的端羟基与亲水物质通过氢键连接,使亲水物质能够更牢固地结合到成膜物质上,避免亲水性物质发生脱落或溶出等现象;而且聚醚砜具有优异的机械性能,将其作为支撑层纺丝溶液有利于提高中空纤维复合膜的结构强度;此外,本实施例中通过分开调控分离层纺丝溶液和支撑层纺丝溶液的制膜配方,可以制备亲水性分离层,使分离层表面和孔隙形成水化层提高亲水性,以改善中空纤维复合膜的血液相容性,同时可调控分离层壁厚,降低中空纤维复合膜的过滤阻力,而支撑层可以通过调节支撑层纺丝溶液的制膜配方制备多孔层,以进一步降低中空纤维复合膜的过滤阻力,并且分离层纺丝溶液和支撑层纺丝溶液使用结构相似的主体材料,在一步成膜的过程中,能够使分离层和支撑层的界面分子缠绕地更加牢固,使两者的结合强度更加稳定。The preparation method of the hollow fiber composite membrane provided in this example uses a modified polyethersulfone mixture to prepare a separation layer spinning solution and a support layer spinning solution, and the modified polyethersulfone mixture includes polyethersulfone and/or terminal hydroxyl groups Polyethersulfone, hydroxyl-terminated polyethersulfone is a water-insoluble hydrophilic modified polyethersulfone, which can be blended with polyethersulfone to form a membrane, which can improve the hydrophilic performance of the hollow fiber composite membrane and improve the hollow fiber Blood compatibility of the composite membrane; during the film formation process, the terminal hydroxyl groups in the hydroxyl-terminated polyethersulfone can form hydrogen bonds with hydrophilic substances (such as water-soluble PVP or PEG molecules, etc.), so that the hydrophilic substances are anchored in the The surface of the hollow fiber composite membrane can further improve the blood compatibility of the hollow fiber composite membrane, and the terminal hydroxyl groups in the hydroxyl-terminated polyethersulfone are connected to the hydrophilic substance through hydrogen bonds, so that the hydrophilic substance can be more firmly bound to the component. On the membrane material, the phenomenon of falling off or dissolution of the hydrophilic material is avoided; and polyethersulfone has excellent mechanical properties, and it is beneficial to improve the structural strength of the hollow fiber composite membrane by using it as a supporting layer spinning solution; in addition, this embodiment In the process, the membrane-making formula of the separation layer spinning solution and the support layer spinning solution can be separately adjusted to prepare a hydrophilic separation layer, so that the surface and pores of the separation layer can form a hydration layer to improve hydrophilicity, so as to improve the hollow fiber composite membrane. Hemocompatibility, at the same time, the wall thickness of the separation layer can be adjusted to reduce the filtration resistance of the hollow fiber composite membrane, and the support layer can be prepared by adjusting the membrane formulation of the support layer spinning solution to prepare a porous layer to further reduce the filtration of the hollow fiber composite membrane. Resistance, and the separation layer spinning solution and the support layer spinning solution use the main material with similar structure. In the process of one-step film formation, the interface molecules of the separation layer and the support layer can be entangled more firmly, and the bonding strength of the two can be improved. more stable.

另外,分离层纺丝溶液、支撑层纺丝溶液和芯液通过共挤出工艺通过共挤出工艺制备中空纤维复合膜,能够实现一步成膜,便于规模化生产,且通过共挤出工艺制膜,不仅能够将与血液直接接触的亲水性分离层结合在支撑层上,改善中空纤维复合膜的血液相容性,也可以分开调控分离层和支撑层的制膜配方,优化中空纤维复合膜的结构,改善中空纤维复合膜的性能。In addition, the separation layer spinning solution, the supporting layer spinning solution and the core solution are co-extruded to prepare the hollow fiber composite membrane through the co-extrusion process, which can realize one-step film formation and facilitate large-scale production, and can be produced through the co-extrusion process. The membrane can not only combine the hydrophilic separation layer in direct contact with the blood with the support layer to improve the blood compatibility of the hollow fiber composite membrane, but also can separately control the membrane formulation of the separation layer and the support layer to optimize the hollow fiber composite membrane. The structure of the membrane improves the performance of the hollow fiber composite membrane.

具体地,步骤S100中可以采用如下方法制备分离层纺丝溶液:Specifically, in step S100, the following method can be used to prepare the separation layer spinning solution:

将质量百分比为15%至35%的改性聚醚砜混合物、25%至40%的亲水性添加剂和45%至60%的有机溶剂在30℃至80℃下,搅拌12h至24h直至混合均匀,经过过滤和真空脱泡10h至12h后,制得澄清透明的分离层纺丝溶液。Mix 15% to 35% of the modified polyethersulfone mixture, 25% to 40% of the hydrophilic additive and 45% to 60% of the organic solvent at 30°C to 80°C for 12h to 24h until mixed Evenly, after filtering and vacuum defoaming for 10h to 12h, a clear and transparent spinning solution for the separation layer is obtained.

将分离层纺丝溶液中各组分的用量比例限定在一定的范围内,有利于提高中空纤维复合膜的质量,进一步改善中空纤维复合膜的血液相容性,另外也有利于对分离层的壁厚进行调控,以进一步降低中空纤维复合膜的过滤阻力,有利于提高血液净化的效率。Limiting the dosage ratio of each component in the spinning solution of the separation layer within a certain range is conducive to improving the quality of the hollow fiber composite membrane, further improving the blood compatibility of the hollow fiber composite membrane, and is also beneficial to the separation layer. The wall thickness is adjusted to further reduce the filtration resistance of the hollow fiber composite membrane, which is beneficial to improve the efficiency of blood purification.

其中,改性聚醚砜混合物包括聚醚砜和端羟基化聚醚砜,或者,改性聚醚砜混合物为端羟基化聚醚砜。Wherein, the modified polyethersulfone mixture includes polyethersulfone and hydroxylated polyethersulfone, or the modified polyethersulfone mixture is hydroxylated polyethersulfone.

若改性聚醚砜混合物包括聚醚砜和端羟基化聚醚砜,则聚醚砜和端羟基化聚醚砜可以以任意比例组合,本实施例中不做进一步地限定。例如:聚醚砜与端羟基化聚醚砜可以按照25%的聚醚砜和75%的端羟基化聚醚砜进行混合。If the modified polyethersulfone mixture includes polyethersulfone and hydroxylated polyethersulfone, the polyethersulfone and hydroxylated polyethersulfone can be combined in any ratio, which is not further limited in this embodiment. For example: polyethersulfone and hydroxylated polyethersulfone can be mixed according to 25% polyethersulfone and 75% hydroxylated polyethersulfone.

本实施例中的端羟基化聚醚砜为市场购买得到,该端羟基化聚醚砜的分子结构如下所示:The hydroxylated polyethersulfone in this example is purchased from the market, and the molecular structure of the hydroxylated polyethersulfone is as follows:

本实施例中,亲水性添加剂为聚乙二醇、醋酸纤维素、聚乙烯醇和聚甲基丙烯酸甲酯中的一种或两种的组合,其中,聚乙二醇可以为PEG200、PEG400、PEG600、PEG800和PEG1000中的一种或两种的组合。有机溶剂为磷酸三乙酯、N-甲基甲酰胺、N,N-二甲基乙酰胺、N-甲基吡咯烷酮中的一种或两种的组合。相对于现有技术中的其它种类的亲水性添加剂和有机溶剂,采用上述种类的亲水性添加剂和有机溶剂时,能够进一步改善所得的中空纤维复合膜的亲水性和生物相容性。In this embodiment, the hydrophilic additive is one or a combination of polyethylene glycol, cellulose acetate, polyvinyl alcohol and polymethyl methacrylate, wherein the polyethylene glycol can be PEG200, PEG400, One or a combination of two of PEG600, PEG800 and PEG1000. The organic solvent is one or a combination of triethyl phosphate, N-methylformamide, N,N-dimethylacetamide and N-methylpyrrolidone. Compared with other types of hydrophilic additives and organic solvents in the prior art, the hydrophilicity and biocompatibility of the obtained hollow fiber composite membrane can be further improved when the above-mentioned types of hydrophilic additives and organic solvents are used.

在制备纺丝溶液时,聚醚砜、端羟基化聚醚砜和亲水剂添加剂共同溶解于有机溶剂中,从而实现共混,通过共混和氢键相结合的优点,有利于制得具有良好的血液相容性的中空纤维复合膜,并且也有利于亲水性物质更牢固地结合到改性聚醚砜混合物上。When preparing the spinning solution, polyethersulfone, hydroxylated polyethersulfone and hydrophilic agent additives are dissolved in the organic solvent together to achieve blending. The advantages of blending and hydrogen bonding are conducive to the preparation of a good It is a hollow fiber composite membrane with blood compatibility, and it is also conducive to more firmly binding of hydrophilic substances to the modified polyethersulfone mixture.

具体地,步骤S200中可以采用如下方法制备支撑层纺丝溶液:Specifically, in step S200, the following method can be used to prepare the spinning solution for the support layer:

将质量百分比为10%至25%的改性聚醚砜混合物、5%至30%的增塑剂、15%至40%的致孔剂和30%至65%的有机溶剂在30℃至80℃下,搅拌12h至24h直至混合均匀,经过过滤和真空脱泡10h至12h后,制得澄清透明的支撑层纺丝溶液。The mass percentage is 10% to 25% of the modified polyethersulfone mixture, 5% to 30% of the plasticizer, 15% to 40% of the porogen and 30% to 65% of the organic solvent at 30 ℃ to 80 ℃, stirring for 12h to 24h until the mixture is uniform, and after filtering and vacuum defoaming for 10h to 12h, a clear and transparent spinning solution for the support layer is obtained.

将支撑层纺丝溶液中各组分的用量比例限定在一定的范围内,有利于对支撑层的孔径进行调控,制备得到具有多孔结构的支撑层,以进一步降低中空纤维复合膜的过滤阻力,有利于提高血液净化的效率。Limiting the dosage ratio of each component in the spinning solution of the support layer within a certain range is conducive to regulating the pore size of the support layer and preparing a support layer with a porous structure to further reduce the filtration resistance of the hollow fiber composite membrane. It is beneficial to improve the efficiency of blood purification.

其中,改性聚醚砜混合物包括聚醚砜和端羟基化聚醚砜,或者,改性聚醚砜混合物为聚醚砜。Wherein, the modified polyethersulfone mixture includes polyethersulfone and hydroxylated polyethersulfone, or the modified polyethersulfone mixture is polyethersulfone.

需要说明的是,若分离层纺丝溶液中含有聚醚砜和端羟基化聚醚砜,则支撑层纺丝溶液中可以同时含有聚醚砜和端羟基化聚醚砜,也可以仅仅只含有聚醚砜;若分离层纺丝溶液中含有端羟基化聚醚砜,则支撑层纺丝溶液中可以同时含有聚醚砜和端羟基化聚醚砜,也可以仅仅只含有聚醚砜,只要能够保证分离层纺丝溶液中的改性聚醚砜混合物和支撑层纺丝溶液中的改性聚醚砜混合物能够同时含有聚醚砜和端羟基化聚醚砜,确保聚醚砜和端羟基化聚醚砜共混制膜,从而有利于提高中空纤维复合膜的亲水性能,提高中空纤维复合膜的血液相容性。It should be noted that if the separation layer spinning solution contains polyethersulfone and hydroxylated polyethersulfone, the supporting layer spinning solution can contain polyethersulfone and hydroxylated polyethersulfone at the same time, or only contain Polyethersulfone; if the separation layer spinning solution contains hydroxylated polyethersulfone, the supporting layer spinning solution can contain both polyethersulfone and hydroxylated polyethersulfone, or only polyethersulfone, as long as It can ensure that the modified polyethersulfone mixture in the spinning solution of the separation layer and the modified polyethersulfone mixture in the spinning solution of the support layer can contain polyethersulfone and hydroxylated polyethersulfone at the same time, ensuring that polyethersulfone and terminal hydroxyl Polyether sulfone is blended to form a membrane, which is beneficial to improve the hydrophilic performance of the hollow fiber composite membrane and improve the blood compatibility of the hollow fiber composite membrane.

若改性聚醚砜混合物包括聚醚砜和端羟基化聚醚砜,则聚醚砜和端羟基化聚醚砜可以以任意比例组合,本实施例中不做进一步地限定。例如:聚醚砜与端羟基化聚醚砜可以按照50%的聚醚砜和50%的端羟基化聚醚砜进行混合。If the modified polyethersulfone mixture includes polyethersulfone and hydroxylated polyethersulfone, the polyethersulfone and hydroxylated polyethersulfone can be combined in any ratio, which is not further limited in this embodiment. For example: polyethersulfone and hydroxylated polyethersulfone can be mixed according to 50% polyethersulfone and 50% hydroxylated polyethersulfone.

本实施例中,增塑剂为聚乙烯吡咯烷酮、聚乙二醇、羧甲基纤维素、羟乙基纤维素和聚甲基丙烯酸甲酯中的一种或两种的组合,其中,聚乙烯吡咯烷酮可以为PVPK15、PVPK17、PVPK30和PVPK60中的一种或两种的组合,聚乙二醇可以为PEG8000、PEG10000和PEG20000中的一种或两种的组合。致孔剂为乙醇、乙二醇、异丙醇、乙二醇单甲醚、一缩二乙二醇、二缩二乙二醇和丙三醇中的一种或两种的组合。有机溶剂为磷酸三乙酯、N-甲基甲酰胺、N,N-二甲基乙酰胺、N-甲基吡咯烷酮中的一种或两种的组合。相对于现有技术中的其它种类的增塑剂、致孔剂和有机溶剂,采用上述种类的增塑剂、致孔剂和有机溶剂时,能够进一步改善所得的中空纤维复合膜的过滤阻力,并进一步提高分离层和支撑层的结合强度。In this embodiment, the plasticizer is one or a combination of two of polyvinylpyrrolidone, polyethylene glycol, carboxymethyl cellulose, hydroxyethyl cellulose and polymethyl methacrylate, wherein polyethylene Pyrrolidone can be one or a combination of PVPK15, PVPK17, PVPK30 and PVPK60, and polyethylene glycol can be one or a combination of PEG8000, PEG10000 and PEG20000. The porogen is one or a combination of ethanol, ethylene glycol, isopropanol, ethylene glycol monomethyl ether, diethylene glycol, diethylene glycol and glycerol. The organic solvent is one or a combination of triethyl phosphate, N-methylformamide, N,N-dimethylacetamide and N-methylpyrrolidone. Compared with other types of plasticizers, porogens and organic solvents in the prior art, when using the above-mentioned plasticizers, porogens and organic solvents, the filtration resistance of the hollow fiber composite membrane obtained can be further improved, And further improve the bonding strength of the separation layer and the support layer.

具体地,步骤S300中可以采用如下方法制备初始膜:Specifically, in step S300, the following method can be used to prepare the initial film:

将分离层纺丝溶液、支撑层纺丝溶液和芯液同时从三孔环形喷丝头中挤出,制得初始膜,其中,三孔环形喷丝头包括从内至外依次设置的芯液通道、分离层溶液通道和支撑层溶液通道,芯液从芯液通道挤出,分离层纺丝溶液从分离层溶液通道挤出,支撑层纺丝溶液从支撑层溶液通道挤出。The separation layer spinning solution, the supporting layer spinning solution and the core liquid are simultaneously extruded from the three-hole annular spinneret to prepare the initial membrane, wherein the three-hole annular spinneret includes the core liquid sequentially arranged from the inside to the outside The channel, the separation layer solution channel and the support layer solution channel, the core liquid is extruded from the core liquid channel, the separation layer spinning solution is extruded from the separation layer solution channel, and the support layer spinning solution is extruded from the support layer solution channel.

其中,三孔环形喷丝头的结构如图2所示,该三孔环形喷丝头包括从内至外依次设置的芯液通道200、分离层溶液通道210和支撑层溶液通道220,芯液通道200为圆形通道,分离层溶液通道210和支撑层溶液通道220为环形通道,芯液、分离层纺丝溶液和支撑层纺丝溶液从内至外依次设置,形成血液相容性和机械性能较好的初始膜。Wherein, the structure of the three-hole annular spinneret is as shown in Figure 2, and the three-hole annular spinneret includes a core liquid channel 200, a separation layer solution channel 210 and a support layer solution channel 220 arranged in sequence from the inside to the outside, and the core liquid The channel 200 is a circular channel, the separation layer solution channel 210 and the support layer solution channel 220 are annular channels, and the core liquid, the separation layer spinning solution and the support layer spinning solution are arranged in sequence from the inside to the outside to form blood compatibility and mechanical properties. The initial film with better performance.

制得初始膜之后,初始膜先经过空气段,空气段的相对湿度为30%至90%,温度为30℃至50℃,初始膜在空气段的停留时间为0.5s至1.5s;经过空气段之后,初始膜进入凝固浴中进行凝固,凝固浴的液面高度保持恒定,在凝固浴中充分凝固、成型,制得中空纤维复合膜。After the initial film is prepared, the initial film first passes through the air section, the relative humidity of the air section is 30% to 90%, the temperature is 30°C to 50°C, and the residence time of the initial film in the air section is 0.5s to 1.5s; After the stage, the initial membrane enters the coagulation bath for coagulation, the liquid level of the coagulation bath is kept constant, fully coagulated and formed in the coagulation bath, and the hollow fiber composite membrane is obtained.

本实施例中通过将初始膜先经过空气段再经过凝固浴,有利于使中空纤维复合膜内壁的孔径至中空纤维复合膜外壁的孔径逐渐增大,并减小中空纤维复合膜内壁的厚度,从而降低中空纤维复合膜透析过程中的阻力,有利于提高血液净化的效率。In this embodiment, by passing the initial membrane first through the air section and then through the coagulation bath, it is beneficial to gradually increase the aperture of the inner wall of the hollow fiber composite membrane to the aperture of the outer wall of the hollow fiber composite membrane, and reduce the thickness of the inner wall of the hollow fiber composite membrane. Therefore, the resistance during the dialysis process of the hollow fiber composite membrane is reduced, and the efficiency of blood purification is improved.

本实施例中,芯液可以由致孔剂和有机溶剂混合制得,芯液也可以由水和有机溶剂混合制得。In this embodiment, the core fluid can be prepared by mixing a porogen and an organic solvent, and the core fluid can also be prepared by mixing water and an organic solvent.

为了能够进一步改善所得的中空纤维复合膜的亲水性和生物相容性,致孔剂包括乙醇、乙二醇、异丙醇、乙二醇单甲醚、一缩二乙二醇、二缩二乙二醇和丙三醇中的一种或两种的组合;有机溶剂包括磷酸三乙酯、N-甲基甲酰胺、N,N-二甲基乙酰胺、N-甲基吡咯烷酮中的一种或两种的组合。In order to further improve the hydrophilicity and biocompatibility of the obtained hollow fiber composite membrane, porogens include ethanol, ethylene glycol, isopropanol, ethylene glycol monomethyl ether, diethylene glycol, diethylene glycol One or a combination of diethylene glycol and glycerol; organic solvents include one of triethyl phosphate, N-methylformamide, N,N-dimethylacetamide, and N-methylpyrrolidone one or a combination of two.

本实施例中,凝固浴由水和有机溶剂混合制得,具体地,将质量百分比为40%至90%的水和10%至60%的有机溶剂混合均匀,制得凝固浴。In this embodiment, the coagulation bath is prepared by mixing water and an organic solvent. Specifically, the coagulation bath is prepared by uniformly mixing 40% to 90% water and 10% to 60% organic solvent by mass percentage.

或者,本实施例中,凝固浴由水和致孔剂混合制得,具体地,将质量百分比为30%至80%的水和20%至70%的致孔剂混合均匀,制得凝固浴。Alternatively, in this embodiment, the coagulation bath is prepared by mixing water and a porogen, specifically, the mass percentage is 30% to 80% of water and 20% to 70% of the porogen are uniformly mixed to obtain a coagulation bath .

为了能够进一步改善所得的中空纤维复合膜的亲水性和生物相容性,有机溶剂包括磷酸三乙酯、N-甲基甲酰胺、N,N-二甲基乙酰胺、N-甲基吡咯烷酮中的一种或两种的组合。In order to further improve the hydrophilicity and biocompatibility of the resulting hollow fiber composite membrane, organic solvents include triethyl phosphate, N-methylformamide, N,N-dimethylacetamide, N-methylpyrrolidone one or a combination of the two.

在凝固浴中充分凝固之后,制得中空纤维复合膜之前,还包括,用水洗定型之后的初始膜,水洗完毕后,进行干燥,得到中空纤维复合膜,其中,水洗时水温为80℃至100℃,干燥温度为30℃至60℃。After fully coagulating in the coagulation bath, before preparing the hollow fiber composite membrane, it also includes washing the initial membrane after water washing and drying to obtain a hollow fiber composite membrane, wherein the water temperature during washing is 80 ° C to 100 °C, the drying temperature is 30 °C to 60 °C.

通过水洗能够去除中空纤维复合膜中的添加剂和溶剂等化学物质,这些化学物质的残留量对血液相容性有极大影响,通过干燥去除中空纤维复合膜中的水分,能够消除内应力,提高中空纤维复合膜的尺寸的稳定性。Chemical substances such as additives and solvents in the hollow fiber composite membrane can be removed by washing with water. The residual amount of these chemical substances has a great impact on blood compatibility, and the removal of water in the hollow fiber composite membrane by drying can eliminate internal stress and improve Dimensional stability of hollow fiber composite membranes.

需要说明的是,本实施例中所用的水均为纯化水或血液透析用水。It should be noted that the water used in this embodiment is all purified water or water for hemodialysis.

为了对本发明进行进一步详细说明,下面将结合具体实施例对本发明进行进一步说明。本发明中的实施例中所使用的实验方法如无特殊说明,均为常规方法;本发明中的实施例中所用的材料、试剂等,如无特殊说明,均为市场购买所得,其中,端羟基化聚醚砜购买于SUMITOMO CHEMICAL,型号为Hydroxyl terminatedPES。In order to further describe the present invention in detail, the present invention will be further described below in conjunction with specific examples. The experimental methods used in the examples of the present invention are conventional methods unless otherwise specified; the materials and reagents used in the examples of the present invention are purchased from the market unless otherwise specified. The hydroxylated polyethersulfone was purchased from SUMITOMO CHEMICAL, and the model number was Hydroxyl terminatedPES.

实施例1Example 1

本实施例提供了一种中空纤维复合膜的制备方法,包括如下步骤:This embodiment provides a method for preparing a hollow fiber composite membrane, comprising the following steps:

(1)将70wt%的聚醚砜和30wt%的端羟基聚醚砜搅拌混合均匀,制得改性聚醚砜混合物;将18wt%的改性聚醚砜混合物、40wt%的亲水性添加剂PEG600、52wt%的有机溶剂N,N-二甲基乙酰胺在50℃下,搅拌24h直至混合均匀,经过过滤和真空脱泡12h,制得澄清透明的分离层纺丝溶液;(1) Stir and mix 70wt% polyethersulfone and 30wt% hydroxyl-terminated polyethersulfone to obtain a modified polyethersulfone mixture; mix 18wt% modified polyethersulfone mixture, 40wt% hydrophilic additive PEG600, 52wt% organic solvent N,N-dimethylacetamide at 50°C, stirred for 24 hours until uniformly mixed, filtered and vacuum defoamed for 12 hours, to obtain a clear and transparent spinning solution for the separation layer;

将质量百分比为16%的聚醚砜、8%的增塑剂聚乙烯吡咯烷酮、25%的致孔剂乙二醇单甲醚和51%的有机溶剂N,N-二甲基乙酰胺在50℃下,搅拌24h直至混合均匀,经过过滤和真空脱泡12h后,制得澄清透明的支撑层纺丝溶液;The mass percent is 16% polyethersulfone, 8% plasticizer polyvinylpyrrolidone, 25% porogen ethylene glycol monomethyl ether and 51% organic solvent N,N-dimethylacetamide at 50 At ℃, stir for 24 hours until the mixture is uniform, and after filtering and vacuum defoaming for 12 hours, a clear and transparent spinning solution for the support layer is obtained;

将5wt%的有机溶剂N,N-二甲基乙酰胺和95wt%的水搅拌混合均匀,制得芯液;Stir and mix 5wt% organic solvent N,N-dimethylacetamide and 95wt% water evenly to obtain core liquid;

将70wt%的水和30wt%的有机溶剂N,N-二甲基乙酰胺搅拌混合均匀,制得凝固浴。Stir and mix 70wt% water and 30wt% organic solvent N,N-dimethylacetamide evenly to prepare a coagulation bath.

(2)将分离层纺丝溶液、支撑层纺丝溶液和芯液同时从三孔环形喷丝头中挤出,三孔环形喷丝头包括从内至外依次设置的芯液通道、分离层溶液通道和支撑层溶液通道,芯液从芯液通道挤出,分离层纺丝溶液从分离层溶液通道挤出,支撑层纺丝溶液从支撑层溶液通道挤出,制得初始膜。(2) Extrude the separation layer spinning solution, the support layer spinning solution and the core liquid from the three-hole annular spinneret at the same time, and the three-hole annular spinneret includes core liquid passages, separation layers, The solution channel and the support layer solution channel, the core liquid is extruded from the core liquid channel, the separation layer spinning solution is extruded from the separation layer solution channel, and the support layer spinning solution is extruded from the support layer solution channel to prepare the initial membrane.

(3)使初始膜先经过空气段,空气段的温度和湿度保持恒定,空气段的相对湿度为60%,温度为40℃,初始膜在空气段的停留时间为1s,经过空气段之后,预分相的初始膜进入凝固浴中进行凝固,凝固浴的液面高度保持恒定,预分相的初始膜在凝固浴中充分凝固后进入清洗水槽,清洗水槽的温度为90℃,清洗完毕后,清洗之后的初始膜进入循环热风干燥箱,在45℃下进行干燥,得到中空纤维复合膜。(3) Make the initial film first pass through the air section, the temperature and humidity of the air section remain constant, the relative humidity of the air section is 60%, the temperature is 40°C, and the initial film's residence time in the air section is 1s, after passing through the air section, The pre-separated initial film enters the coagulation bath for coagulation. The liquid level of the coagulation bath remains constant. The pre-separated initial film is fully solidified in the coagulation bath and then enters the cleaning water tank. The temperature of the cleaning water tank is 90 ° C. After cleaning , and the cleaned initial membrane enters a circulating hot air drying oven and is dried at 45° C. to obtain a hollow fiber composite membrane.

本实施例中制得的中空纤维复合膜的断面电镜图如图3所示,本实施例中制得的中空纤维复合膜分离层的断面电镜图如图4所示。由图3至图4可以看出,本实施例中制得的中空纤维复合膜的分离层和支撑层的界面结合地比较牢固,有利于提高中空纤维复合膜的机械强度,且支撑层为多孔结构,分离层的壁厚较小,有利于降低中空纤维复合膜的过滤阻力,提高血液净化的效率。The cross-sectional electron micrograph of the hollow fiber composite membrane prepared in this example is shown in FIG. 3 , and the cross-sectional electron micrograph of the separation layer of the hollow fiber composite membrane prepared in this example is shown in FIG. 4 . As can be seen from Figures 3 to 4, the interface between the separation layer and the support layer of the hollow fiber composite membrane prepared in this example is relatively firm, which is conducive to improving the mechanical strength of the hollow fiber composite membrane, and the support layer is porous Structure, the wall thickness of the separation layer is small, which is beneficial to reduce the filtration resistance of the hollow fiber composite membrane and improve the efficiency of blood purification.

实施例2Example 2

本实施例提供了一种中空纤维复合膜的制备方法,本实施例中中空纤维复合膜的制备方法与实施例1的制备方法基本相同,不同之处在于分离层纺丝溶液和支撑层纺丝溶液中各组分的配比不同,具体地:This example provides a preparation method of a hollow fiber composite membrane, the preparation method of the hollow fiber composite membrane in this example is basically the same as that of Example 1, the difference is that the separation layer spinning solution and the support layer spinning The proportioning ratio of each component in the solution is different, specifically:

将20wt%的聚醚砜和80wt%的端羟基聚醚砜搅拌混合均匀,制得改性聚醚砜混合物;将18wt%的改性聚醚砜混合物、35wt%的亲水性添加剂PEG600、57wt%的有机溶剂N,N-二甲基乙酰胺在50℃下,搅拌24h直至混合均匀,经过过滤和真空脱泡12h,制得澄清透明的分离层纺丝溶液;Stir and mix 20wt% polyethersulfone and 80wt% hydroxyl-terminated polyethersulfone to obtain a modified polyethersulfone mixture; mix 18wt% modified polyethersulfone mixture, 35wt% hydrophilic additive PEG600, 57wt% % organic solvent N, N-dimethylacetamide at 50°C, stirred for 24 hours until uniformly mixed, filtered and vacuum defoamed for 12 hours, to obtain a clear and transparent spinning solution for the separation layer;

将质量百分比为16%的聚醚砜、8%的增塑剂聚乙烯吡咯烷酮、28%的致孔剂丙三醇和48%的有机溶剂N,N-二甲基乙酰胺在50℃下,搅拌24h直至混合均匀,经过过滤和真空脱泡12h后,制得澄清透明的支撑层纺丝溶液。The mass percent is 16% polyethersulfone, 8% plasticizer polyvinylpyrrolidone, 28% porogen glycerol and 48% organic solvent N,N-dimethylacetamide at 50°C, stirring After 24 hours until the mixture is uniform, after filtration and vacuum defoaming for 12 hours, a clear and transparent spinning solution for the support layer is obtained.

实施例3Example 3

本实施例提供了一种中空纤维复合膜的制备方法,本实施例中中空纤维复合膜的制备方法与实施例1的制备方法基本相同,不同之处在于分离层纺丝溶液和支撑层纺丝溶液中各组分的配比不同,具体地:This example provides a preparation method of a hollow fiber composite membrane, the preparation method of the hollow fiber composite membrane in this example is basically the same as that of Example 1, the difference is that the separation layer spinning solution and the support layer spinning The proportioning ratio of each component in the solution is different, specifically:

改性聚醚砜混合物仅仅为端羟基聚醚砜;将18wt%的改性聚醚砜混合物、35wt%的亲水性添加剂PEG600、57wt%的有机溶剂N,N-二甲基乙酰胺在50℃下,搅拌24h直至混合均匀,经过过滤和真空脱泡12h,制得澄清透明的分离层纺丝溶液;The modified polyethersulfone mixture is only hydroxyl-terminated polyethersulfone; 18wt% of the modified polyethersulfone mixture, 35wt% of the hydrophilic additive PEG600, 57wt% of the organic solvent N,N-dimethylacetamide at 50 At ℃, stir for 24 hours until the mixture is uniform, and filter and vacuum defoam for 12 hours to obtain a clear and transparent spinning solution for the separation layer;

将质量百分比为15%的聚醚砜、10%的增塑剂聚乙烯吡咯烷酮、27%的致孔剂丙三醇和48%的有机溶剂N,N-二甲基乙酰胺在50℃下,搅拌24h直至混合均匀,经过过滤和真空脱泡12h后,制得澄清透明的支撑层纺丝溶液。The mass percent is 15% polyethersulfone, 10% plasticizer polyvinylpyrrolidone, 27% porogen glycerol and 48% organic solvent N,N-dimethylacetamide at 50°C, stirring After 24 hours until the mixture is uniform, after filtration and vacuum defoaming for 12 hours, a clear and transparent spinning solution for the support layer is obtained.

实施例4Example 4

本实施例提供了一种中空纤维复合膜的制备方法,本实施例中中空纤维复合膜的制备方法与实施例1的制备方法基本相同,不同之处在于分离层纺丝溶液和支撑层纺丝溶液中各组分的配比不同,具体地:This example provides a preparation method of a hollow fiber composite membrane, the preparation method of the hollow fiber composite membrane in this example is basically the same as that of Example 1, the difference is that the separation layer spinning solution and the support layer spinning The proportioning ratio of each component in the solution is different, specifically:

将20wt%的聚醚砜和80wt%的端羟基聚醚砜搅拌混合均匀,制得改性聚醚砜混合物;将18wt%的改性聚醚砜混合物、35wt%的亲水性添加剂PEG400、57wt%的有机溶剂N,N-二甲基乙酰胺在50℃下,搅拌24h直至混合均匀,经过过滤和真空脱泡12h,制得澄清透明的分离层纺丝溶液;Stir and mix 20wt% polyethersulfone and 80wt% hydroxyl-terminated polyethersulfone to obtain a modified polyethersulfone mixture; mix 18wt% modified polyethersulfone mixture, 35wt% hydrophilic additive PEG400, 57wt% % organic solvent N, N-dimethylacetamide at 50°C, stirred for 24 hours until uniformly mixed, filtered and vacuum defoamed for 12 hours, to obtain a clear and transparent spinning solution for the separation layer;

将质量百分比为8%的聚醚砜、8%的端羟基聚醚砜、9%的增塑剂聚乙烯吡咯烷酮、25%的致孔剂乙二醇单甲醚和50%的有机溶剂N,N-二甲基乙酰胺在50℃下,搅拌24h直至混合均匀,经过过滤和真空脱泡12h后,制得澄清透明的支撑层纺丝溶液。The mass percentage is 8% polyethersulfone, 8% hydroxyl-terminated polyethersulfone, 9% plasticizer polyvinylpyrrolidone, 25% porogen ethylene glycol monomethyl ether and 50% organic solvent N, N-dimethylacetamide was stirred at 50° C. for 24 hours until uniformly mixed. After filtering and vacuum defoaming for 12 hours, a clear and transparent spinning solution for the support layer was obtained.

对实施例1至实施例4的中空纤维复合膜的性能进行测试,主要采用内表面接触角、复钙时间、溶血率来表征中空纤维复合膜的血液相容性,其中内表面接触角越小,说明中空纤维复合膜表面亲水性越好;复钙时间越长,溶血率越低,说明血液相容性越好。具体测试方法如下:The performance of the hollow fiber composite membranes of Examples 1 to 4 is tested, and the blood compatibility of the hollow fiber composite membranes is mainly characterized by inner surface contact angle, recalcification time, and hemolysis rate, wherein the smaller the inner surface contact angle , indicating that the surface hydrophilicity of the hollow fiber composite membrane is better; the longer the recalcification time, the lower the hemolysis rate, indicating the better blood compatibility. The specific test method is as follows:

1、内表面接触角测试1. Inner surface contact angle test

将中空纤维复合膜样品平铺贴在载物平台上,调平基线,然后向膜表面滴加约5μL去离子水,调节转动测定仪,读取接触角。每根中空纤维复合膜均测量三个平行样品,每个样上取7个测试点,取测试结果的平均值。Lay the hollow fiber composite membrane sample flat on the loading platform, level the baseline, then drop about 5 μL of deionized water on the surface of the membrane, adjust the rotation measuring instrument, and read the contact angle. Three parallel samples were measured for each hollow fiber composite membrane, 7 test points were taken on each sample, and the average value of the test results was taken.

2、复钙时间(PRT)测试2. Recalcification time (PRT) test

(1)取5mL牛全血,离心(2000g,约4411r/min,10min),取上清液,得到贫血小板血浆(PPP);(1) Take 5mL bovine whole blood, centrifuge (2000g, about 4411r/min, 10min), and take the supernatant to obtain platelet-poor plasma (PPP);

(2)将中空纤维复合膜放入24孔细胞培养板中,标号,在37℃恒温水浴中将0.1mL上述PPP滴加到膜表面,保持一分钟;(2) Put the hollow fiber composite membrane into a 24-well cell culture plate, label, and drop 0.1mL of the above PPP onto the surface of the membrane in a constant temperature water bath at 37°C for one minute;

(3)将0.1mL预热到37℃的0.025mol/L的CaCl 2溶液滴加到上述膜表面,观察出现第一根纤维蛋白丝时停止计时,并记录复钙时间。(3) Add 0.1 mL of 0.025 mol/L CaCl 2 solution preheated to 37°C dropwise on the surface of the membrane, stop timing when the first fibrin filament appears, and record the recalcification time.

3、溶血率(HR)测试3. Hemolysis rate (HR) test

(1)将中空纤维复合膜用去离子水洗膜10min,然后用质量分数为0.9%的NaCl溶液洗膜10min;(1) Wash the hollow fiber composite membrane with deionized water for 10 minutes, and then wash the membrane with 0.9% NaCl solution for 10 minutes;

(2)将膜在温度为37℃质量分数为0.9%的NaCl溶液中浸泡30min;(2) Soak the membrane in a NaCl solution with a mass fraction of 0.9% at a temperature of 37° C. for 30 minutes;

(3)将200μL的牛全血分别加入有膜的NaCl溶液、无膜的NaCl溶液以及纯水中,37℃下恒温1h;(3) Add 200 μL of bovine whole blood to NaCl solution with membrane, NaCl solution without membrane and pure water respectively, and keep the temperature at 37°C for 1 hour;

(4)将上述样品离心(800g,约2790r/min,10min),取上层清液,用紫外分光光度计在545nm处测试吸光度。0.9wt%的NaCl水溶液为阴性对照,去离子水为阳性对照,溶血率由下面公式(1)计算出来:(4) Centrifuge the above sample (800g, about 2790r/min, 10min), take the supernatant, and measure the absorbance at 545nm with a UV spectrophotometer. The NaCl aqueous solution of 0.9wt% is a negative control, and deionized water is a positive control, and the hemolysis rate is calculated by the following formula (1):

HR=(AS-AN)/(AP-AN)×100%公式(1)HR=(AS-AN)/(AP-AN)×100% formula (1)

式中:AS—样品的吸光度;AN—阴性对照的吸光度;AP—阳性对照的吸光度。In the formula: AS—absorbance of sample; AN—absorbance of negative control; AP—absorbance of positive control.

将上述制备得到的中空纤维复合膜应用于血浆成分分离,去除血液中的致病物质(致病物质取决于疾病的种类),以实现本发明的一种应用场合,比如,重症自身免疫性疾病(SAID),利用双重血浆置换治疗,直接清除血浆中的免疫复合物、免疫球蛋白、补体等致病因子,并使患者细胞免疫功能及网状内皮细胞吞噬功能恢复,及时阻断SAID发生发展的环节,就能达到缓解病情的目的。The hollow fiber composite membrane prepared above is applied to the separation of plasma components to remove pathogenic substances in the blood (pathogenic substances depend on the type of disease) to realize an application of the present invention, such as severe autoimmune diseases (SAID), using double plasma exchange therapy, directly removes immune complexes, immunoglobulins, complement and other pathogenic factors in the plasma, and restores the patient's cellular immune function and reticuloendothelial cell phagocytosis, and blocks the occurrence and development of SAID in time link, can achieve the purpose of relieving the disease.

实施例1至实施例4制备得到的中空纤维复合膜,经加工处理,制得中空纤维血浆成分分离器,有效膜面积为1.0m2。血浆为新鲜抗凝牛血,37℃的牛血浆The hollow fiber composite membranes prepared in Examples 1 to 4 were processed to obtain a hollow fiber plasma component separator with an effective membrane area of 1.0 m 2 . Plasma is fresh anticoagulated bovine blood, bovine plasma at 37°C

控制血浆入口流量为100ml/min,滤过液流量为25ml/min,废弃血浆流量5-10ml/min,处理时间3h。通过确定溶液中和过滤前血浆中每种蛋白的浓度来评价膜性能。Control the plasma inlet flow rate to 100ml/min, the filtrate flow rate to 25ml/min, the waste plasma flow rate to 5-10ml/min, and the processing time to 3h. Membrane performance was evaluated by determining the concentration of each protein in solution and in pre-filtered plasma.

清除率(%)=(1-滤液中的浓度/原液中的浓度)×100%Clearance rate (%)=(1-concentration in filtrate/concentration in stock solution)×100%

对中空纤维复合膜进行溶血率的测试,对中空纤维复合膜制成的血浆成分分离器进行免疫球蛋白的清除性能测试,测试结果如表1所示。The hemolysis rate of the hollow fiber composite membrane was tested, and the immunoglobulin clearance performance test was performed on the plasma component separator made of the hollow fiber composite membrane. The test results are shown in Table 1.

表1Table 1

由表1可以看出,与实施例1相比,实施例2至实施例4中的中空纤维复合膜的内表面接触角均有较大幅度的下降,说明中空纤维复合膜的分离层中端羟基聚醚砜的含量增加,有利于提高膜内表面的亲水性能;并且实施例2至实施例4中的中空纤维复合膜的复钙时间均长于实施例1中的中空纤维复合膜的复钙时间,实施例2至实施例4中的中空纤维复合膜的溶血率均低于实施例1中的中空纤维复合膜的溶血率,说明随着中空纤维复合膜的分离层中端羟基聚醚砜的含量增加,溶血率降低,复钙时间增加,有利于提高中空纤维复合膜的血液相容性。实施例4的中空纤维复合膜的分离层和支撑层中均含有端羟基聚醚砜和聚醚砜,与实施例2和实施例3的中空纤维复合膜中仅仅只有分离层同时含有端羟基聚醚砜和聚醚砜相比,有利于进一步提高整个膜断面的血液相容性。It can be seen from Table 1 that compared with Example 1, the inner surface contact angles of the hollow fiber composite membranes in Examples 2 to 4 all have a relatively large decrease, indicating that the middle end of the separation layer of the hollow fiber composite membrane The content of hydroxyl polyether sulfone increases, which is conducive to improving the hydrophilic performance of the membrane inner surface; Calcium time, the hemolysis rate of the hollow fiber composite membrane in embodiment 2 to embodiment 4 is all lower than the hemolysis rate of the hollow fiber composite membrane in embodiment 1, illustrates that with the separation layer of the hollow fiber composite membrane, the terminal hydroxyl polyether The content of sulfone increases, the rate of hemolysis decreases, and the recalcification time increases, which is beneficial to improve the blood compatibility of the hollow fiber composite membrane. Both the separation layer and the support layer of the hollow fiber composite membrane of Example 4 contain hydroxyl-terminated polyethersulfone and polyethersulfone, and in the hollow fiber composite membranes of Examples 2 and 3, only the separation layer contains hydroxyl-terminated polyethersulfone. Compared with polyethersulfone, ethersulfone is beneficial to further improve the blood compatibility of the entire membrane section.

实施例1至实施例4中的中空纤维复合膜可以用于血浆成分分离器,以清除血液中的免疫球蛋白、补体、免疫复合物、大分子脂蛋白等各类致病因子,而分子质量较小的白蛋白可以通过膜孔渗透回输到患者体内,因此达到去除血液中有害成分,治疗疾病的目的。采用实施例1至实施例4中的中空纤维复合膜进行免疫球蛋白的清除性能测试,测试结果表面,实施例1至实施例4中制备得到的中空纤维复合膜对免疫球蛋白均表现出良好的清除性能,其中实施例2中制得的中空纤维复合膜对IgG,IgM,IgA三种免疫球蛋白表现出的清除性能最为突出。The hollow fiber composite membranes in Examples 1 to 4 can be used in plasma component separators to remove various pathogenic factors such as immunoglobulins, complements, immune complexes, and macromolecular lipoproteins in the blood, and the molecular mass Smaller albumin can be infiltrated back into the patient's body through the membrane pores, thus achieving the purpose of removing harmful components in the blood and treating diseases. Adopt the hollow fiber composite membrane in embodiment 1 to embodiment 4 to carry out the scavenging performance test of immunoglobulin, the test result surface, the hollow fiber composite membrane prepared in embodiment 1 to embodiment 4 all shows good to immunoglobulin Clearance performance, wherein the hollow fiber composite membrane prepared in Example 2 has the most outstanding clearance performance for IgG, IgM, and IgA three kinds of immunoglobulins.

为了对本发明进行进一步详细说明,下面将结合具体实施例对本发明进行进一步说明。本发明中的实施例中所使用的实验方法如无特殊说明,均为常规方法;本发明中的实施例中所用的材料、试剂等,如无特殊说明,均为市场购买所得。In order to further describe the present invention in detail, the present invention will be further described below in conjunction with specific examples. The experimental methods used in the examples of the present invention are conventional methods unless otherwise specified; the materials and reagents used in the examples of the present invention are purchased from the market unless otherwise specified.

Claims (7)

1. The preparation method of the hollow fiber composite membrane is characterized by comprising the following steps:
uniformly mixing a modified polyethersulfone mixture, a hydrophilic additive and an organic solvent to prepare a separation layer spinning solution, wherein the hydrophilic additive is one or a combination of two of polyethylene glycol, cellulose acetate, polyvinyl alcohol and polymethyl methacrylate;
uniformly mixing a modified polyethersulfone mixture, a plasticizer, a pore-forming agent and an organic solvent to prepare a supporting layer spinning solution, wherein the plasticizer is one or two of polyvinylpyrrolidone, polyethylene glycol, carboxymethyl cellulose, hydroxyethyl cellulose and polymethyl methacrylate, and the pore-forming agent is one or two of ethanol, ethylene glycol, isopropanol, ethylene glycol monomethyl ether, diethylene glycol and glycerol;
the separation layer spinning solution, the support layer spinning solution and the core solution form an initial membrane through a coextrusion process, and the initial membrane is solidified and cleaned to obtain a hollow fiber composite membrane;
wherein the modified polyethersulfone mixture in the spinning solution of the separation layer comprises polyethersulfone and hydroxyl-terminated polyethersulfone, or the modified polyethersulfone mixture in the spinning solution of the separation layer is hydroxyl-terminated polyethersulfone;
the modified polyethersulfone mixture in the supporting layer spinning solution comprises polyethersulfone and hydroxyl-terminated polyethersulfone, or the modified polyethersulfone mixture in the supporting layer spinning solution is polyethersulfone.
2. The method for preparing a hollow fiber composite membrane according to claim 1, wherein the spinning solution for the separation layer is prepared by the following method:
mixing 15-35% of modified polyethersulfone mixture, 25-40% of hydrophilic additive and 45-60% of organic solvent at 30-80 ℃ for 12-24 hours, filtering and vacuum defoaming to obtain the spinning solution.
3. The method for preparing a hollow fiber composite membrane according to claim 1, wherein the support layer spinning solution is prepared by the following method:
10 to 25 mass percent of modified polyethersulfone mixture, 5 to 30 mass percent of plasticizer, 15 to 40 mass percent of pore-forming agent and 30 to 65 mass percent of organic solvent are mixed for 12 to 24 hours at 30 to 80 ℃, and the spinning solution of the support layer is prepared after filtration and vacuum deaeration.
4. The method for producing a hollow fiber composite membrane according to claim 1, wherein,
the organic solvent is one or the combination of two of triethyl phosphate, N-methyl formamide, N-dimethyl acetamide and N-methyl pyrrolidone.
5. The method for preparing a hollow fiber composite membrane according to claim 1, wherein the initial membrane is prepared by the following method:
and extruding the separation layer spinning solution, the support layer spinning solution and the core solution from a three-hole annular spinneret simultaneously to prepare an initial membrane, wherein the three-hole annular spinneret comprises a core solution channel, a separation layer solution channel and a support layer solution channel which are sequentially arranged from inside to outside, the core solution is extruded from the core solution channel, the separation layer spinning solution is extruded from the separation layer solution channel, and the support layer spinning solution is extruded from the support layer solution channel.
6. The method for producing a hollow fiber composite membrane according to claim 1, wherein the initial membrane is coagulated by:
the initial film is sequentially solidified through an air section and a coagulating bath, wherein the relative humidity of the air section is 30-90%, the temperature is 30-50 ℃, and the residence time of the initial film in the air section is 0.5-1.5 s; the coagulating bath is prepared by mixing water and a pore-forming agent, or the coagulating bath is prepared by mixing water and an organic solvent, and the liquid level of the coagulating bath is kept constant.
7. A hollow fiber composite membrane produced by the method for producing a hollow fiber composite membrane according to any one of claims 1 to 6.
CN202211021897.7A 2022-08-24 2022-08-24 A kind of hollow fiber composite membrane and its preparation method and application Active CN115400600B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202211021897.7A CN115400600B (en) 2022-08-24 2022-08-24 A kind of hollow fiber composite membrane and its preparation method and application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202211021897.7A CN115400600B (en) 2022-08-24 2022-08-24 A kind of hollow fiber composite membrane and its preparation method and application

Publications (2)

Publication Number Publication Date
CN115400600A CN115400600A (en) 2022-11-29
CN115400600B true CN115400600B (en) 2023-08-04

Family

ID=84162534

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202211021897.7A Active CN115400600B (en) 2022-08-24 2022-08-24 A kind of hollow fiber composite membrane and its preparation method and application

Country Status (1)

Country Link
CN (1) CN115400600B (en)

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1103814A (en) * 1993-12-18 1995-06-21 中国科学院生态环境研究中心 Method for fabricating composite hellow fibre ultrafiltration film and the products
US5462867A (en) * 1988-10-17 1995-10-31 Hemasure, Inc. Covalent attachment of macromolecules to polysulfones or polyethersulfones modified to contain functionalizable chain ends
EP1078947A1 (en) * 1999-08-26 2001-02-28 Akzo Nobel N.V. Hydrophile polyethersulfones and process for their preparation
CN101791520A (en) * 2010-04-06 2010-08-04 东华大学 Polyether sulfone/hydroxyapatite composite membrane and preparation method and application thereof
KR101370806B1 (en) * 2013-05-02 2014-03-12 한국과학기술연구원 Sulfonated polyethersulfone copolymer containing hydroxyl groups and preparation method thereof, polymer electrolyte membrane for fuel cells and membrane electrode assembly comprising the same
CN111225729A (en) * 2017-08-21 2020-06-02 俄亥俄州创新基金会 Membrane for gas separation
CN113905807A (en) * 2019-05-31 2022-01-07 旭化成株式会社 Forward osmosis membrane and forward osmosis membrane module and method of making the same

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5462867A (en) * 1988-10-17 1995-10-31 Hemasure, Inc. Covalent attachment of macromolecules to polysulfones or polyethersulfones modified to contain functionalizable chain ends
CN1103814A (en) * 1993-12-18 1995-06-21 中国科学院生态环境研究中心 Method for fabricating composite hellow fibre ultrafiltration film and the products
EP1078947A1 (en) * 1999-08-26 2001-02-28 Akzo Nobel N.V. Hydrophile polyethersulfones and process for their preparation
CN101791520A (en) * 2010-04-06 2010-08-04 东华大学 Polyether sulfone/hydroxyapatite composite membrane and preparation method and application thereof
KR101370806B1 (en) * 2013-05-02 2014-03-12 한국과학기술연구원 Sulfonated polyethersulfone copolymer containing hydroxyl groups and preparation method thereof, polymer electrolyte membrane for fuel cells and membrane electrode assembly comprising the same
CN111225729A (en) * 2017-08-21 2020-06-02 俄亥俄州创新基金会 Membrane for gas separation
CN113905807A (en) * 2019-05-31 2022-01-07 旭化成株式会社 Forward osmosis membrane and forward osmosis membrane module and method of making the same

Also Published As

Publication number Publication date
CN115400600A (en) 2022-11-29

Similar Documents

Publication Publication Date Title
US4935141A (en) Selectively permeable asymmetric membranes suitable for use in hemodialysis and processes for manufacturing such membranes
CN1125669C (en) Polysulfone hollow fiber semipermeable membrane
JP4587079B2 (en) High flux dialysis membrane with improved separation behavior
JPWO2002009857A1 (en) Modified hollow fiber membrane
CN100457242C (en) Dialysis membrane having improved average molecular distance
JPH06205954A (en) New high flux hollow fiber membrane
JP5857407B2 (en) Hollow fiber membrane and method for producing hollow fiber membrane
JP5129962B2 (en) Integral asymmetric membrane, method for producing the same and use thereof
JP3366040B2 (en) Polysulfone-based semipermeable membrane and method for producing the same
JP3617194B2 (en) Permselective separation membrane and method for producing the same
JP3966481B2 (en) Semipermeable membrane
CN115253731B (en) Hollow fiber membrane and preparation method and application thereof
CN115400600B (en) A kind of hollow fiber composite membrane and its preparation method and application
JPWO2013129384A1 (en) Adsorption column
JP3314861B2 (en) Hollow fiber membrane
JPH053335B2 (en)
JP2020533166A (en) Microporous membrane and its manufacturing method
JP3424810B2 (en) High performance blood purification membrane
JP4810720B2 (en) Selective removal membrane and blood processor using the same
JP3995228B2 (en) Hollow fiber membrane for blood purification
JP4381058B2 (en) Hollow fiber blood purifier with excellent blood compatibility
JP4003982B2 (en) Polysulfone-based selectively permeable separation membrane
JPH08970A (en) Hollow fiber membrane
JP2000107577A (en) Production of permselective hollow fiber membranes
JPH09308684A (en) Selective separating membrane

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
CP01 Change in the name or title of a patent holder
CP01 Change in the name or title of a patent holder

Address after: 519085 No. 98 Science and Technology Sixth Road, Zhuhai High-tech Zone, Guangdong Province

Patentee after: JAFRON BIOMEDICAL Co.,Ltd.

Patentee after: Zhuhai Jianfan Blood Purification Technology Co.,Ltd.

Address before: 519085 No. 98 Science and Technology Sixth Road, Zhuhai High-tech Zone, Guangdong Province

Patentee before: JAFRON BIOMEDICAL Co.,Ltd.

Patentee before: Zhuhai Jianhang Medical Technology Co.,Ltd.